Validated : Actualité Validated en direct - P1 | Bourse Reflex
Accueil > Tags > Validated

  • Toutes les actualités en rapport avec « Validated »

30/03 18:00 Validated - QWAMPLIFY - General Assembly adopts new Group name and appoints 2 new administrators

19/03 07:30 Validated - Partnership between Nexteam Group and Prodways Group focusing on new RAF technology for the 3D printing of titanium parts

19/03 07:30 Validated - Partnership between Nexteam Group and Prodways Group focusing on new RAF technology for the 3D printing of titanium parts

13/11 18:00 Validated - FIRST-QUARTER 2017/18 REVENUE

23/10 12:30 Validated - QuantumClean® et ChemTrace® participeront au salon SEMICON Europa 2017

28/06 07:30 Validated - Quantum Genomics announces the design of its next Phase II trial in arterial hypertension, NEW-HOPE

30/03 18:00 Validated - 2016 annual financial results and next development steps in 2017

28/07 17:45 Validated - First half 2016 sales: EUR 85m (+113%)

26/07 11:00 Validated - FINANCIAL YEAR 2015/16 REVENUE

13/06 18:35 Validated - GENTICEL ANNOUNCES COMPLETION OF TWO MAJOR MILESTONES IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

22/03 18:00 Validated - NATUREX and Swisse strengthen their business ties

19/10 16:35 Validated - Apricus Biosciences Announces Issuance of Korean Patent, Expanding Its Patent Portfolio for Its Topical Cream to Treat Premature Ejaculation

14/10 08:30 Validated - Apricus Biosciences Announces New Data Published in the International Journal of Pharmaceutics Confirming Efficiency of NexACT(R) Drug Delivery Technology

06/10 16:05 Validated - Apricus Biosciences to Present Poster of Femprox(R) Phase III Clinical Data at Upcoming Industry Conference

03/10 20:05 Validated - Apricus Biosciences Announces Korean Patent Approval for MycoVa(TM) for Nail Fungus

13/09 14:05 Validated - Crucial to Support Next-Generation Intel(R) Server Platform With New Server Memory

12/09 08:15 Validated - Apricus Biosciences to Provide Overview of Rx and Consumer Healthcare Divisions at the 11th Annual Biotech in Europe Investor Forum

31/08 16:20 Validated - Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

23/08 14:05 Validated - New Crucial 8GB Memory Modules Optimize Desktop and Laptop Performance

18/08 15:00 Validated - Photo Release -- Apricus Biosciences Announces FDA Clearance for Its First Anti-Fungal OTC Drug (Tolnaftate-D(TM)) Containing NexACT(R) Technology